iSpecimen (ISPC) Gross Profit (2020 - 2025)
iSpecimen has reported Gross Profit over the past 6 years, most recently at -$690744.0 for Q4 2025.
- For Q4 2025, Gross Profit fell 446.69% year-over-year to -$690744.0; the TTM value through Dec 2025 reached $376378.0, down 92.96%, while the annual FY2025 figure was $24110.0, 99.42% down from the prior year.
- Gross Profit for Q4 2025 was -$690744.0 at iSpecimen, down from -$98001.0 in the prior quarter.
- Over five years, Gross Profit peaked at $4.2 million in Q4 2021 and troughed at -$690744.0 in Q4 2025.
- A 5-year average of $1.4 million and a median of $1.5 million in 2022 define the central range for Gross Profit.
- Biggest five-year swings in Gross Profit: soared 175.06% in 2024 and later tumbled 446.69% in 2025.
- Year by year, Gross Profit stood at $4.2 million in 2021, then plummeted by 82.3% to $735197.0 in 2022, then soared by 56.14% to $1.1 million in 2023, then tumbled by 82.64% to $199241.0 in 2024, then tumbled by 446.69% to -$690744.0 in 2025.
- Business Quant data shows Gross Profit for ISPC at -$690744.0 in Q4 2025, -$98001.0 in Q3 2025, and $454753.0 in Q2 2025.